Renee D Gala Net Worth - Insider Trades and Bio as of Jun 7, 2026

JAZZJazz Pharmaceuticals plcSEC CIK: 0001607737

Estimated Net Worth

$50.5 Million

Last Updated: May 19, 2026 11:41 PM EST

Transaction Summary

Total Transactions62

Buy-Sell Ratio0.50

Buy Transactions2

Sell Transactions4

Transaction Volume

Total Volume-$2.87M

Net Volume$3.42M

Buy Volume$276.85K

Sell Volume-$3.14M

Trade Analysis

AVG Trade Size-$169.00K

Largest Trade$155.10K

Most Active MonthMar

Most Active Year2025

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Renee D Gala has an estimated net worth of $50.5 Million. This is based on reported shares across multiple companies, which include Theravance Biopharma, Inc., Gossamer Bio, Inc., CORCEPT THERAPEUTICS INC, Jazz Pharmaceuticals plc, and DEXCOM INC.

2025 was Renee D Gala's most active year for acquiring shares with 7 total transactions. Renee D Gala's most active month to acquire stocks was the month of January. 2018 was Renee D Gala's most active year for disposing of shares, totalling 8 transactions. Renee D Gala's most active month to dispose stocks was the month of July. 2018 saw Renee D Gala paying a total of $155,101.50 for 77,750 shares, this is the most they've acquired in one year. In 2026 Renee D Gala cashed out on 12,436 shares for a total of $2,252,395.21, their largest year based on trade value.

Holdings & Transactions

JAZZjazz pharmaceuticals plc

President & CEO Officer

Updated: Mar 09, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.04	7.07K	$188.69	-$1.33M	Mar 09, 2026	152.63K	Tax	—	Mar 05	View
From 4	0.39	44.47K	—	—	Mar 02, 2026	159.70K	Grant	—	Feb 26	View
From 4	0.07	7.37K	$171.16	-$919.30K	Jan 21, 2026	115.23K	Grant	—	Jan 16	View
From 4	-0.00	80.00	$166.91	-$13.35K	Dec 09, 2025	107.86K	Tax	—	Dec 05	View
From 4	0.21	18.81K	—	—	Aug 11, 2025	107.87K	Grant	—	Aug 07	View
From 4	-0.06	5.70K	$138.95	-$792.57K	Mar 07, 2025	88.90K	Disposition	—	Mar 05	View
From 4	0.58	34.67K	—	—	Mar 03, 2025	94.60K	Grant	—	Feb 27	View
From 4	0.08	4.44K	$122.62	-$404.65K	Jan 22, 2025	59.93K	Grant	—	Jan 17	View
From 4	-0.00	80.00	$123.45	-$9.88K	Dec 09, 2024	55.49K	Tax	—	Dec 05	View
From 4	-0.03	1.74K	$115.21	-$200.00K	Apr 09, 2024	55.36K	Tax	—	Apr 05	View
From 4	-0.06	3.62K	$117.53	-$425.69K	Mar 07, 2024	57.09K	Tax	—	Mar 05	View
From 4	0.49	19.92K	—	—	Mar 05, 2024	60.72K	Grant	—	Mar 01	View
From 4	0.10	3.88K	$119.13	-$381.69K	Jan 19, 2024	40.80K	Grant	—	Jan 17	View
From 4	0.02	772.00	—	—	Nov 14, 2023	36.89K	Grant	—	Nov 10	View
From 4	-0.14	6.00K	$131.75	-$790.47K	May 19, 2023	35.98K	Sale	—	May 18	View
From 4	-0.04	1.81K	$145.78	-$263.42K	Apr 07, 2023	41.98K	Tax	—	Apr 05	View
From 4	0.34	11.23K	$142.78	-$222.31K	Mar 07, 2023	43.79K	Grant	—	Mar 03 - 05	View
From 4	-0.07	2.63K	$160.00	-$421.60K	Dec 22, 2022	32.56K	Sale	Scheduled	Dec 21	View
From 4	-0.04	1.63K	$162.88	-$265.98K	Apr 07, 2022	35.00K	Tax	—	Apr 05	View
From 4	0.43	11.01K	$153.96	-$110.85K	Mar 09, 2022	36.63K	Acquisition	—	Mar 03 - 05	View
From 4	-0.06	1.51K	$164.71	-$249.54K	Apr 07, 2021	25.35K	Tax	—	Apr 05	View
From 4	0.60	10.12K	—	—	Mar 01, 2021	26.86K	Grant	—	Feb 25	View
From 4	—	58.10K	—	—	May 11, 2020	58.10K	Grant	—	May 07	View
From 3	—	—	—	—	Mar 18, 2020	—	—	—	—	View

DXCMdexcom inc

Updated: Jul 07, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	0.20	1.16K	—	—	Jul 07, 2025	6.88K	Grant	—	May 08	View
From 4	0.89	5.07K	—	—	May 12, 2025	10.79K	Grant	—	May 08	View
From 4	—	5.72K	—	—	Mar 10, 2025	5.72K	Grant	—	Mar 06	View
From 3	—	—	—	—	Mar 10, 2025	—	—	—	—	View

GOSSgossamer bio, inc.

Updated: Jun 09, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	35.00K	—	—	Jun 09, 2023	35.00K	Grant	—	Jun 08	View
From 4	—	30.00K	—	—	Jul 15, 2022	30.00K	Grant	—	Jun 09	View
From 4	—	23.50K	—	—	Jun 10, 2021	23.50K	Grant	—	Jun 09	View
From 4	—	23.50K	—	—	Jun 18, 2020	23.50K	Grant	—	Jun 17	View
From 4	—	23.50K	—	—	Jun 11, 2019	23.50K	Grant	—	Jun 10	View
From 3	—	—	—	—	Feb 07, 2019	—	—	—	—	View

TBPHtheravance biopharma, inc.

SVP, Chief Financial Officer Officer

Updated: Nov 21, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.04	6.70K	$24.79	-$166.02K	Nov 21, 2018	157.66K	Tax	—	Nov 20	View
From 4	-0.04	6.70K	$26.95	-$180.43K	Aug 22, 2018	164.35K	Tax	—	Aug 20	View
From 4	-0.20	43.74K	$26.79	-$1.17M	Aug 16, 2018	171.05K	Sale	—	Aug 14 - 15	View
From 4	-0.13	31.23K	$24.30	-$758.98K	May 22, 2018	214.79K	Sale	—	May 18 - 20	View
From 4	0.16	33.75K	—	—	May 16, 2018	246.02K	Grant	—	May 14	View
From 4	-0.02	5.39K	$29.09	-$156.71K	Feb 22, 2018	211.41K	Tax	—	Feb 20	View
From 4	0.04	9.00K	—	—	Feb 14, 2018	216.79K	Grant	—	Feb 12	View
From 4	-0.03	6.75K	$28.58	-$193.00K	Nov 22, 2017	207.79K	Tax	—	Nov 20	View
From 4	-0.03	6.75K	$27.40	-$185.00K	Aug 22, 2017	214.55K	Tax	—	Aug 20	View
From 4	-0.03	6.75K	$36.83	-$248.71K	May 23, 2017	221.30K	Tax	—	May 20	View
From 4	-0.04	10.21K	$33.78	-$344.93K	Feb 22, 2017	226.35K	Tax	—	Feb 20	View
From 4	0.04	9.00K	—	—	Feb 08, 2017	236.56K	Grant	—	Feb 06	View
From 4	-0.02	4.63K	$31.96	-$147.91K	Nov 22, 2016	227.56K	Tax	—	Nov 20	View
From 4	-0.02	4.31K	$27.89	-$120.09K	Aug 23, 2016	232.19K	Tax	—	Aug 20	View
From 4	-0.01	3.33K	$20.55	-$68.49K	May 24, 2016	236.50K	Tax	—	May 20	View
From 4	0.61	90.00K	—	—	Mar 17, 2016	238.13K	Grant	—	Mar 15	View
From 4	-0.08	13.05K	$15.65	-$204.26K	Feb 23, 2016	148.13K	Tax	—	Feb 20	View
From 4	0.03	10.00K	$12.18	$121.75K	Aug 17, 2015	315.46K	Purchase	—	Aug 13 - 17	View
From 4	9.45	135.00K	—	—	Feb 09, 2015	149.28K	Grant	—	Feb 05	View
From 4	-0.01	158.00	$26.98	-$4.26K	Aug 22, 2014	14.28K	Tax	—	Aug 20	View
From 4	—	85.00K	—	—	Jul 23, 2014	85.00K	Grant	—	Jul 21	View
From 4	—	85.00K	—	—	Jun 05, 2014	85.00K	Grant	—	Jun 03	View
From 3	—	—	—	—	May 14, 2014	—	—	—	—	View

CORTcorcept therapeutics inc

Updated: Aug 22, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	25.00K	—	—	Aug 22, 2018	25.00K	Grant	—	Aug 20	View
From 4	—	10.00K	$15.51	$155.10K	Mar 07, 2018	10.00K	Purchase	—	Mar 06 - 07	View
From 4	—	30.00K	—	—	May 26, 2017	30.00K	Grant	—	May 24	View
From 4	—	70.00K	—	—	Jun 28, 2016	70.00K	Grant	—	Jun 27	View
From 3	—	—	—	—	Jun 28, 2016	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions